WHO ICTRP trial
An open-label, multi-center, 24-month extension study to evaluate the safety of…
EUCTR2008-007467-17-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-007467-17-FR |
|---|---|
| Public title | An open-label, multi-center, 24-month extension study to evaluate the safety of ranibizumab as symptomatic treatment for visual impairment due to diabetic macular edema in patients who have completed the RESTORE trial - RESTORE EXTENSION |
| Scientific title | An open-label, multi-center, 24-month extension study to evaluate the safety of ranibizumab as symptomatic treatment for visual impairment due to diabetic macular edema in patients who have completed the RESTORE trial - RESTORE EXTENSION |
| Primary sponsor | Novartis Pharma Services AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France;Hungary;Belgium;Spain;Germany;Netherlands;Italy;United Kingdom |
| Conditions | Diabetic Macular Edema (DME) MedDRA version: 9.1 Level: LLT Classification code 10057934 Term: Diabetic macular edema |
| Interventions | Trade Name: Lucentis Product Name: Lucentis Product Code: RFB002D Pharmaceutical Form: Solution for injection INN or Proposed INN: Ranibizumab Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number… |
| Registration date | Jan 4, 2009 |
| Target size | 320 |
| Secondary IDs | RFB002D2301E1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: